Robert P. Roche

Robert P.
Roche is currently a Director at Catalent Maryland, Inc. and a Trustee at Bryn Mawr Hospital Foundation.
He is also a Member of Robert Roche Associates LLC.
Previously, he served as a Director at LifeCell Corp.
from 2005 to 2008, Director at Intercept Pharmaceuticals, Inc. from 2008 to 2011, Independent Director at EKR Therapeutics, Inc. in 2011, Independent Director at NuPathe, Inc. from 2010 to 2014, Independent Director at Aratana Therapeutics, Inc. from 2014 to 2019, and Independent Director at Zyla Life Sciences LLC from 2016 to 2019.
He also served as Director & Vice President at GSK Plc, Director & Managing Director at Smithkline Beecham Research Ltd., and Director at Civitas Therapeutics, Inc. from 2012 to 2014.
He was the Executive VP-Worldwide Pharmaceutical Operations at Cephalon, Inc. from 2005 to 2010.
He also served as a Director at Smithkline Beecham Pharmaceuticals (Canada).
He has been a Trustee at Westtown School.
He received his undergraduate degree from Colgate University and his MBA from The Wharton School of the University of Pennsylvania.